State of the art in natural killer cell malignancies

International Journal of Laboratory Hematology

Volumn 34, Issue 2, 2012, Pages 117-128

  Semenzato, G ^a   Marino, F ^a   Zambello, R ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Natural killer cells; NK cell malignancies

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BORTEZOMIB; CD56 ANTIGEN; CD94 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DASATINIB; METHOTREXATE; STEROID;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGGRESSIVE NK CELL LEUKEMIA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NATURAL KILLER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; LYMPHATIC SYSTEM TUMOR; NATURAL KILLER CELL; NATURAL KILLER CELL LYMPHOBLASTIC LEUKEMIA; NATURAL KILLER CELL LYMPHOBLASTIC LYMPHOMA; NATURAL KILLER CELL LYMPHOMA; NATURAL KILLER CELL MALIGNANCY; NATURAL KILLER CELL YMPHOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PRECANCER; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME;

HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, LYMPHOID; LYMPHOMA; PROGNOSIS; WORLD HEALTH ORGANIZATION;

EID: 84857444304     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2011.01374.x     Document Type: Review

References (67)

1. Borowitz M.J., Béné M.C., Harris N.L., Porwit A. & Matutes E. (2008) Acute leukemias of ambigous lineage. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (eds S.H. Swerdlow, E. Campo, N.L. Harris, E.J. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J. Vardiman ), 155. IARC, Lyon.
2. Caligiuri M. (2008) Human natural killer cells. Blood 112, 461-469.
3. Chan J.K., Sin V.C., Wong K.F., Ng C.S., Tsang W.Y., Chan C.H., Cheung M.M. & Lau W.H. (1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89, 4501-4514.
4. Chan J.K.C., Jaffe E.S., Ralfkiaer E. & Ko Y.K. (2008a) Aggressive NK-leukemia. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (eds S.H. Swerdlow, E. Campo, N.L. Harris, E.J. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J. Vardiman ), 276-277. IARC, Lyon.
5. Chan J.K.C., Quintanilla-Martinez N.L., Ferry J.A. & Peh S.C. (2008b) Extranodal NK/T-cell lymphoma, nasal type. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (eds S.H. Swerdlow, E. Campo, N.L. Harris, E.J. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J. Vardiman ), 285-288. IARC, Lyon.
6. Chang S.S., Liao Y.L., Lin S.H. & Chuang S.S. (2010) NK-cell lymphoma with nodal presentation and expression of cutaneous lymphocyte-associated antigen. Pathology Research and Practise 206, 463-466.
7. Cheung M.M., Chan J.K., Lau W.H., Foo W., Chan P.T., Ng C.S. & Ngan R.K. (1998) Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. Journal of Clinical Oncology 16, 70-77.
8. Epling-Burnette P.K., Sokol L., Chen X., Bai F., Zhou J., Blaskovich M.A., Zou J., Painter J.S., Edwards T.D., Moscinski L., Yoder J.A., Djeu J.Y., Sebti S., Loughran T.P. Jr & Wei S. (2008) Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling. Blood 112, 4694-4698.
9. Fernandez L.A., Pope B., Lee C. & Zayed E. (1986) Aggressive natural killer cell leukemia in an adult with establishment of an NK line. Blood 67, 925-930.
10. Gattazzo C., Teramo A., Miorin M., Scquizzato E., Cabrelle A., Balsamo M., Agostini C., Vendrame E., Facco M., Albergoni M.P., Trentin L., Vitale M., Semenzato G. & Zambello R. (2010) Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes. Haematologica 95, 1722-1729.
11. Greer J.P. (2006) Therapy of peripheral T/NK neoplasms. Hematology American Society Hematology Education Program, 331-337.
12. Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F. & Osato T. (1990) Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335, 128-130.
13. Harabuchi Y., Takahara M., Kishibe K., Moriai S., Nagato T. & Ishii H. (2009) Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features. International Journal of Clinical Oncology 14, 181-190.
14. Hodge D.L., Yang J., Buschman M.D., Schaughency P.M., Dang H., Bere W., Yang Y., Savan R., Subleski J.J., Yin X.M., Loughran T.P. Jr & Young H.A. (2009) Interleukin-15 enhances proteasomal degradation of Bid in normal lymphocytes: implications for large granular lymphocyte leukemias. Cancer Research 69, 3986-3994.
15. Hoshida Y., Hongyo T., Xu J.X., Sasaki T., Tomita Y., Nomura T. & Aozasa K. (2003) Analysis of p53, K-ras, c-kit, and beta-catenin gene mutations insinonasal NK/T cell lymphoma in northeast district of China. Cancer Science 94, 297-301.
16. Huang Y., de Reyniès A., de Leval L., Ghazi B., Martin-Garcia N., Travert M., Bosq J., Brière J., Petit B., Thomas E., Coppo P., Marafioti T., Emile J.F., Delfau-Larue M.H., Schmitt C. & Gaulard P. (2010) Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood 115, 1226-1237.
17. Iqbal J., Weisenburger D.D., Chowdhury A., Tsai M.Y., Srivastava G., Greiner T.C., Kucuk C., Deffenbacher K., Vose J., Smith L., Au W.Y., Nakamura S., Seto M., Delabie J., Berger F., Loong F., Ko Y.H., Sng I., Liu X., Loughran T.P., Armitage J., Chan W.C. & International Peripheral T-cell Lymphoma Project. (2011) The International Peripheral T-cell Lymphoma Project. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase a inhibitor in vitro. Leukemia 25, 348-358.
18. Ishihara S., Ohshima K., Tokura Y., Yabuta R., Imaishi H., Wakiguchi H., Kurashige T., Kishimoto H., Katayama I., Okada S. & Kawa-Ha K. (1997) Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Japanese Journal of Cancer Research, 88, 82-87.
19. Jaccard A., Gachard N., Marin B., Rogez S., Audrain M., Suarez F., Tilly H., Morschhauser F., Thieblemont C., Ysebaert L., Devidas A., Petit B., de Leval L., Gaulard P., Feuillard J., Bordessoule D., Hermine O., GELA and GOELAMS Intergroup (2011) Efficacy of l-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood 117, 1834-1839.
20. Jaffe E.S. (1996) Classification of natural killer (NK) cell and NK-like T cell malignancies. Blood 87, 1207-1210.
21. Kanno H., Kojya S., Li T., Ohsawa M., Nakatsuka S., Miyaguchi M., Harabuchi Y. & Aozasa K. (2000) Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology. International Journal of Cancer 87, 195-199.
22. Kawa-Ha K., Ishihara S., Ninomiya T., Yumura-Yagi K., Hara J., Murayama F., Tawa A. & Hirai K. (1989) CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. Journal of Clinical Investigation 84, 51-55.
23. Kim D.H., Kamel-Reid S., Chang H., Sutherland R., Jung C.W., Kim H.J., Lee J.J. & Lipton J.H. (2009) Natural Killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia. Haematologica 94, 135-139.
24. Kwong Y.L. (2005) Natural killer-cell malignancies: diagnosis and treatment. Leukemia 19, 2186-2194.
25. Kwong Y.L., Chan A.C., Liang R., Chiang A.K., Chim C.S., Chan T.K., Todd D. & Ho F.C. (1997) CD56+ NK lymphomas: clinicopathological features and prognosis. British Journal Haematology 97, 821-829.
26. Lamy T. & Loughran T.P. Jr (2011) How we treat LGL leukemia. Blood 117, 2764-2774.
27. Lanier L.L., Spits H. & Phillips J.H. (1992) The developmental relationship between NK cells and T cells. Immunology Today 13, 392-395.
28. Li T., Hongyo T., Syaifudin M., Nomura T., Dong Z., Shingu N., Kojya S., Nakatsuka S., Aozasa K. (2007) Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma. Virus Genes 34, 47-54.
29. Liang X. & Graam G.K. (2008) Natural Killer cell neoplasms. Cancer 112, 1425-1436.
30. Lin C.W., Liu T.Y., Chen S.U., Wang K.T., Medeiros L.J. & Hsu S.M. (2005) CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features. Blood 106, 3567-3574.
31. Liu X., Ryland L., Yang J., Liao A., Aliaga C., Watts R., Tan S.F., Kaiser J., Shanmugavelandy S.S., Rogers A., Loughran K., Petersen B., Yuen J., Meng F., Baab K.T., Jarbadan N.R., Broeg K., Zhang R., Liao J., Sayers T.J., Kester M. & Loughran T.P. Jr (2010) Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia. Blood 116, 4192-4201.
32. López-Botet M., Pérez-Villar J.J., Carretero M., Rodríguez A., Melero I., Bellón T., Llano M. & Navarro F. (1997) Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immmunology Reviews 155, 165-174.
33. Loughran T.P. Jr (1993) Clonal diseases of large granular lymphocytes. Blood 82, 1-14.
34. Loughran T.P. Jr, Hadlock K.G., Yang Q., Perzova R., Zambello R., Semenzato G., Foung S.K. & Poiesz B.J. (1997) Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes. Blood 90, 1977-1981.
35. Maghazachi A.A. (2010) Role of chemokines in the biology of natural killer cells. Current Topics Microbiology Immunology 870, 37-58.
36. Makishima H., Ito T., Momose K., Nakazawa H., Shimodaira S., Kamijo Y., Nakazawa Y., Ichikawa N., Ueno M., Kobayashi H., Kitano K., Saito H., Kiyosawa K. & Ishida F. (2007) Chemokine system and tissue infiltration in aggressive NK-cell leukemia. Leukemia Research 31, 1237-1245.
37. Minarovits J., Hu L.F., Imai S., Harabuchi Y., Kataura A., Minarovits-Kormuta S., Osato T. & Klein G. (1994) Clonality, expression and methylation patterns of the EBV genomes in lethal midline granulomas classified as peripheral angiocentric T-cell lymphomas. Journal of Genetic Virology 75, 77-84.
38. Moretta L. (2010) Dissecting CD56dim human NK cells. Blood 116(19), 3689-3691.
39. Moretta A., Locatelli F. & Moretta L. (2008) Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemia. Immunology Reviews 224, 58-69.
40. Nakashima Y., Tagawa H., Suzuki R., Karnan S., Karube K., Ohshima K., Muta K., Nawata H., Morishima Y., Nakamura S. & Seto M. (2005) Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration pattern of aggressive NK-leukemia and extranodal NK/T cell lymphoma, nasal type. Genes Chromosomes Cancer 44, 247-255.
41. Oshima K., Haraokaa S., Ishihara S., Ohgami A., Yoshioka S., Suzumiya J. & Kikuchi M. (2002) Analysis of chromosome 6q deletion in EBV-associated NK cell leukemia/lymphoma. Leukemia and Lymphoma 43, 293-300.
42. Oshimi K. (1996) Lymphoproliferative disorders of natural killer cells. International Journal of Hematology 63, 279-290.
43. Oshimi K. (2007) Progress in understanding and managing natural killer cell-malignancies. British Journal of Haematology 139, 532-544.
44. Pandolfi F., Loughran T.P. Jr, Starkebaum G., Chisesi T., Barbui T., Chan W.C., Brouet J.C., De Rossi G., McKenna R.W. & Salsano F. (1990) Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study. Cancer 65, 341-348.
45. Petrella T., Comeau M.R., Maynadié M., Couillault G., De Muret A., Maliszewski C.R., Dalac S., Durlach A. & Galibert L. (2002) "Agranular CD4+ CD56+ hematodermic neoplasm" (blastic NK-cell lymphoma) originated from a population of CD56+ precursor cells related to plasmacytoid monocytes. American Journal of Surgical Pathology 26, 852-862.
46. Ribrag V., Ell Hajj M., Janot F., Girinsky T., Domenge C., Schwaab G., Fenaux P. & Bosq J. (2001) Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 15, 1123-1126.
47. Sakata K., Hareyama M., Ohuchi A., Sido M., Nagakura H., Morita K., Harabuchi Y. & Kataura A. (1997) Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncologica 36, 307-311.
48. Sánchez M.J., Muench M.O., Roncarolo M.G., Lanier L.L. & Phillips J.H. (1994) Identification of a common T/natural killer cell progenitor in human fetal thymus. Journal of Experimental Medicine 180, 569-576.
49. - myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 84, 244-255.
50. Semenzato G., Pandolfi F., Chisesi T., De Rossi G., Pizzolo G., Zambello R., Trentin L., Agostini C., Dini E. & Vespignani M. (1987) The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 60, 2971-2978.
51. Semenzato G., Zambello R., Starkebaum G., Oshimi K. & Loughran T.P. Jr (1997) The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 89, 256-260.
52. Shen L., Liang A.C., Lu L., Au W.Y., Kwong Y.L., Liang R.H. & Srivastava G. (2002) Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma. American Journal of Pathology 161, 2123-2131.
53. Siu L.L.P., Chan J.K.C. & Kwong Y.L. (2002) Natural killer cell malignancies: clinicopathologic and molecular features. Histology and Histopathology 17, 539-554.
54. Stewart C.A., Walzer T., Robbins S.H., Malissen B., Vivier E. & Prinz I. (2007) Germ-line and rearranged TCRδ transcription distinguish bona fide NK cells and NK-like γδ T cell. European Journal of Immunology 37, 1442-1452.
55. Suzuki R., Suzumiya J., Nakamura S., Aoki S., Notoya A., Ozaki S. et al. & NK-cell Tumor Study Group (2004) Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 18(4), 763-770.
56. Suzumiya J., Takeshita M., Kimura N., Kikuchi M., Uchida T., Hisano S., Eura Y., Kozuru M., Nomura Y. & Tomita K. (1994) Expression of adult and fetal natural killer cell markers in sinunasal lymphomas. Blood 83, 2255-2260.
57. Swerdlow S.H., Webber S.A., Chadburn A. & Ferry J.A. (2008) Post-transplant lymphoproliferative disorders. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (eds S.H. Swerdlow, E. Campo, N.L. Harris, E.J. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J. Vardiman ), 349. IARC, Lyon.
58. Takahashi E., Asano N., Li C., Tanaka T., Shimada K., Shimada S., Yoshino T., Kojima M., Hara K., Eimoto T. & Nakamura S. (2008) Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases. Histopathology 52, 585-596.
59. Tefferi A., Li C.Y., Witzig T.E., Dhodapkar M.V., Okuno S.H. & Phyliky R.L. (1994) Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood 84, 2721-2725.
60. Trinchieri G. (1989) Biology of natural killer cells. Advances in Immunology 47, 187-376.
61. Villamor N., Morice W.G., Chan W.C. & Foucar K. (2008) Chronic lymphoproliferative disorders of NK cells. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (eds S.H. Swerdlow, E. Campo, N.L. Harris, E.J. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J. Vardiman ), 274-275. IARC, Lyon.
62. Wendt K., Wilk E., Buyny S., Buer J., Schmidt R.E. & Jacobs R. (2006) Gene and protein characteristics reflect functional diversity of CD56dim and CD56 bright NK cells. Journal of Leukocyte Biology 80, 1529-1541.
63. Wong K.F., Chan J.K. & Kwong Y.L. (1997) Identification of del (6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukemia. British Journal of Haematology 98, 922-926.
64. Zambello R. & Semenzato G. (2003) Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes. Seminars in Hematology 40, 201-212.
65. Zambello R. & Semenzato G. (2009) Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches. Haematologica 94, 1341-1345.
66. Zambello R., Falco M., Della Chiesa M., Trentin L., Carollo D., Castriconi R., Cannas G., Carlomagno S., Cabrelle A., Lamy T., Agostini C., Moretta A., Semenzato G. & Vitale M. (2003) Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative disease of granular lymphocytes. Blood 102, 1797-1805.
67. Zambello R., Berno T., Cannas G., Baesso I., Binotto G., Bonoldi E., Bevilacqua P., Miorin M., Facco M., Trentin L., Agostini C. & Semenzato G. (2005) Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL). Blood 102, 1797-1805.